Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Exact Sciences Presents Data Demonstrating Advancement in Blood-based Colorectal Cancer Screening at ESMO 2024
-
Starcore Reports Q1 Results
-
SolGold PLC Announces Company Update
-
Dubai to Host Dubai Woodshow’s 21st Edition, from April 14th to 16th, 2025
-
Aktsiaselts Infortar signed a share purchase agreement to acquire a 100% shareholding at Tallinna Raamatutrükikoja Osaühing
-
Syensqo announces voluntary delisting from Euronext Paris
-
Curatis: Significantly Increased Sales in Core Business and Projects in Development Pipeline on Track
-
Autoliv Appoints Adriana Karaboutis to its Board of Directors
-
SEB initiates coverage of Aktia and publishes initiation analysis
-
Share repurchase programme
-
Exor Press Release - Periodic Report on the Buyback Program
-
i3 Energy PLC Announces Interview in relation to Gran Tierra transaction
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - Sept 16
-
Genomes.io Launches a Dedicated $GENOME Fund, Aiming to Build the Fastest-Growing Genomic Database With Over 1 Billion Genomes by 2029
-
Thor Explorations Announces the Acquisition of the Guitry Project and Expansion into Cote D'Ivoire
-
PetroTal Announces Q3 2024 Dividend Payment & Grant of Performance Share Units for Dividend Equivalents
-
Market Logic Software unveils new DeepSights™ release: Unlocking unprecedented value from corporate knowledge systems
-
Rivada, Peraton Join Forces for Global Mission-Critical Connectivity
-
Broadridge Announces First High-Quality Liquidity Asset Use Case for its Distributed Ledger Repo Platform
-
International ID Day: Thales Stands up for a Legal and Trusted Identity for Everyone
-
Hoffmann Green Reports Robust Half-Year Revenue Growth and Continues Executing Its Strategic Roadmap
-
Juniper Research: Quantum Computing - Commercial Revenue to Near $10bn Globally by 2030
-
OKX Wallet and Uniswap Labs to Host 'Swap to the Future' Exhibition Event in Singapore
-
Natural Biohack For Lowering Anxiety: Pulsetto Vagus Nerve Stimulator Updated
-
OKX Wallet and Uniswap Labs to Host 'Swap to the Future' Exhibition Event in Singapore
-
MaxCyte Signs Strategic Platform License with Kamau Therapeutics to Accelerate the Development of Cell Therapies for Genetic Diseases
-
AAVantgarde announces first patient dosed in First-In-Human Phase 1/2 LUCE-1 study, evaluating AAVB-081 (Dual-AAV) in retinitis pigmentosa related to Usher Syndrome type 1B
-
Tonner Drones: Board and Management Changes Lead to Further Debt Reduction
-
Intermediate Capital Group plc : Directorate change
-
Net Asset Value(s)
-
Transaction in Own Shares
-
RIBER announces coverage initiation of its stock by TP ICAP Midcap
-
Web3 and AI-Powered Platform Colle AI Expands NFT Generator to Include Video Creation
-
Personalize Your Workspace: The Ultimate Guide to Custom Mouse Pads
-
ENHANCING FRAUD AND THEFT INVESTIGATIONS: THE ROLE OF C.R.E
-
Sampo plc: Directed issuance of new Sampo A shares to Topdanmark shareholders in connection with the exchange offer
-
Sampo plc increases its share buyback programme to EUR 475 million and extends it until 30 November 2024
-
The ICAPE Group Announces a Major Acquisition to Become One of the Leading Players in PCB Distribution in Japan
-
Sampo plc: Final result of the exchange offer to the shareholders of Topdanmark
-
Vallourec Enhances Its Line Pipe Coating Solutions With the Acquisition of Thermotite do Brasil
-
BGHL (EUR): NAV(s)
-
BGHL (GBP): NAV(s)
-
Sampo plc’s share buybacks 13 September 2024
-
The Eurofins Network Expands Its BioPharma Product Testing Offering in the United States With the Acquisition of Infinity Laboratories, Inc.
-
Platinum Group Metals Ltd. Announces Positive Independent Definitive Feasibility Study Update for the Waterberg Mine
-
University of Kalba Selects Banner SaaS to Support Institutional Growth
-
VeriPark Wins Three Top Honors from IDC
-
Start of Day Message
-
FDA approves OCREVUS ZUNOVO™ as the first and only twice-a-year 10-minute subcutaneous injection for people with relapsing and progressive multiple sclerosis
-
China patent notification boosts PolTREG’s development of Treg cell therapy in multiple sclerosis
